Navigation Links
PeerJ publishes its first articles
Date:2/12/2013

PeerJ, a new academic journal publisher, founded on the principles of affordability, innovation, and Open Access, published its first articles today.

PeerJ, launched by Jason Hoyt (formerly at Mendeley and Stanford University) and Peter Binfield (formerly at PLOS ONE), has been shaped from the premise that 'if society can set a goal to sequence a human genome for just $99 then why shouldn't academics be given the opportunity to openly publish their research for a similar amount?'. By publishing its first 30 peer-reviewed articles today, PeerJ moves one step closer to realizing that vision.

"We are doing things that no other publisher is doing," said Hoyt, Co-Founder and CEO of PeerJ. "It has been reported that the global academic community pays as much as $9.5B per year for access to academic journals. We believe that these costs could be reduced by as much as 75% using new business models such as that employed by PeerJ, and utilizing open distribution licenses such as the Creative Commons license. The result will be a net benefit to the global research effort and a welcome increase in the efficiency and effectiveness of academic publication."

PeerJ aims to establish a new model for the publication of all well reported, scientifically sound research in the Biological and Medical Sciences. To achieve that, the organization has built an economical and efficient peer review and publication system and assembled an Editorial Board of 800 esteemed academics, including an Advisory Board of 20 (five of whom are Nobel Laureates). A rigorous peer review process is operated, and the journal strives to deliver the highest standards in everything it does.

Uta Francke, an author on one of the launch day articles; PeerJ Advisory Board member; Professor of Genetics and Pediatrics, Emeritus, Stanford University School of Medicine; and Past President of both the 'American Society of Human Genetics' and the 'International Federation of Human Genetics Societies' said that she was "excited about the launch of PeerJ, which represents much more than just another Open Access publishing venture. The innovative membership model, including a commitment to review the work of one's peers, will ensure an interactive relationship of equals - authors, editors and reviewers - all striving for high quality research reports published in a totally transparent fashion after rigorous constructive peer review."

Tim O'Reilly, the founder of O'Reilly Media and a thought leader in the Open Source movement, sits on the Governing Board of PeerJ Inc. and brings a wealth of knowledge, and passion, for the promotion of open, unfettered communication in academia. Tim had this to say about PeerJ: "It's easy to forget that technological revolutions also demand business model revolutions. Open access is transformative for science publishing, not only because it spreads knowledge more efficiently, but because it slashes the cost of producing and consuming that knowledge."

Authors wishing to experience the future of publishing can now submit their articles at: https://peerj.com/


'/>"/>

Contact: Peter Binfield
pete@peerj.com
415-413-4596
PeerJ
Source:Eurekalert  

Related biology news :

1. Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings
2. Professor publishes on first-ever imaging of cells growing on spherical surfaces
3. NYBG press publishes final volume of landmark Intermountain Flora series
4. The ENCODE Project publishes new genomic insights in special issue of Genome Research
5. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
6. First-in-man study demonstrates the therapeutic effect of RNAi gene silencing in cancer treatment
7. Animal magnetism: First evidence that magnetism helps salmon find home
8. Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young
9. U. of Minn. researchers unveil first artificial enzyme created by evolution in a test tube
10. Study of human specimen collections in the US offers first look at their huge diversity
11. Canada launches first gene therapy trial for Fabry disease
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PeerJ publishes its first articles
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/29/2016)... , March 29, 2016 LegacyXChange, ... LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to announce ... used in a variety of writing instruments, ensuring athletes ... originally created collectibles from athletes on LegacyXChange will be ... of the DNA. Bill Bollander , ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... CLEVELAND , June 27, 2016  Global ... average 4.6 percent through 2020 to $7.2 billion.  ... (food and beverages, cleaning products, biofuel production, animal ... and biotechnology, diagnostics, and biocatalysts). Food and beverages ... gains driven by increasing consumption of products containing ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
Breaking Biology Technology: